Literature DB >> 343953

Prolonged survival after renal transplantation in primary hyperoxaluria of childhood.

E P Leumann, W Wegmann, F Largiadèr.   

Abstract

Cadaver renal transplantation was performed in a 14-year-old girl with primary hyperoxaluria. Acute tubular necrosis was present initially, and a moderate rejection crisis occurred at 6 weeks. Renal biopsy performed at 4 months showed considerable deposition of calcium oxalate. Urinary excretion of oxalate varied between 315-371 mg/24 hr per 1.73 m2 (normal less than 50 mg). Despite these unfavourable factors, renal function has remained stable for the last 2 1/2 years; the serum creatinine is 1.5 mg/100 ml at 3 years. This is the longest surviving graft reported so far in documented primary hyperoxaluria. Graft failures in previous reports could in part be explained by additional complicating factors. It is concluded that renal transplantation is not necessarily contraindicated in primary hyperoxaluria.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 343953

Source DB:  PubMed          Journal:  Clin Nephrol        ISSN: 0301-0430            Impact factor:   0.975


  4 in total

1.  [Type I oxalosis in childhood--studies within the scope of terminal renal failure in the child].

Authors:  M Frosch; E Kuwertz-Bröking; M Bulla; D B von Bassewitz; D B Leusmann
Journal:  Klin Wochenschr       Date:  1989-11-17

Review 2.  [Recurrence of the original disease in the transplanted kidney].

Authors:  E P Leumann; J Briner
Journal:  Klin Wochenschr       Date:  1984-04-02

3.  The outcome of 304 primary renal transplants in children (1968-1985).

Authors:  J S Najarian; S K So; R L Simmons; D S Fryd; T E Nevins; N L Ascher; D E Sutherland; W D Payne; B M Chavers; S M Mauer
Journal:  Ann Surg       Date:  1986-09       Impact factor: 12.969

4.  Successful renal transplantation in primary hyperoxaluria.

Authors:  P O'Regan; A R Constable; A M Joekes; G P Kasidas; G A Rose
Journal:  Postgrad Med J       Date:  1980-04       Impact factor: 2.401

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.